From our experts
In this rapidly evolving landscape, transparency is not just a regulatory buzzword – it is a competitive advantage.
In 2025, the average American working full-time earns about $66,622 a year. Now consider this: the average annual cost of specialty drugs is $84,000 a year.
Many employers still rely on pharmacy benefit managers (PBMs) and traditional formularies that don’t reflect market efficiency or real-world value. But here’s the thing: you don’t have to absorb these costs.
It’s projected that by 2027, 56% of total insurance spend will go to specialty medications. But what if that same slice could be shrunk down to just 17%?
Self‑funding is no longer restricted to Fortune 500 companies.
